Deciphering Anticancer Mechanisms of Calycosin in Lung Adenocarcinoma Through Multi-Omics: Targeting SMAD3-Mediated NOTCH Signaling in the Tumor Microenvironment
Open Access
Abstract
Objective: Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related mortality, particularly in advanced stages. This study investigates the anticancer mechanisms of calycosin, an isoflavonoid derived from Astragalus membranaceus, in LUAD. Methods: Using integrative approaches including bulk and single-cell RNA sequencing, network pharmacology, and molecular docking, we identified SMAD3 as a critical biomarker associated with LUAD staging and prognosis. Results: Calycosin targets SMAD3, modulating the NOTCH signaling pathway in monocytes/macrophages to suppress tumor growth, invasion, and immune evasion. Enrichment analyses revealed significant involvement of NOTCH signaling components in SMAD3-correlated genes, particularly in advanced-stage LUAD. Single-cell RNA sequencing further demonstrated NOTCH pathway enrichment in tumor-associated monocytes/macrophages. Additionally, KMT2A was identified as a key transcriptional regulator in these cells. Conclusions: These findings highlight the potential effects of calycosin and provide novel insights into targeting the tumor–immune microenvironment in LUAD.Keywords
Funding Information
- National Natural Science Foundation of China (8240012013)
- the State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants (The Chinese University of Hong Kong/CUHK) (8240012013)
- Innovation and Technology Commission (8240012013)
- Hong Kong and Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, CUHK (8240012013)
This publication has 43 references indexed in Scilit:
- POH1 induces Smad3 deubiquitination and promotes lung cancer metastasisCancer Letters, 2023
- Stage Shift Improves Lung Cancer Survival: Real-World EvidenceJournal of Thoracic Oncology, 2022
- Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinomaCancer Immunology, Immunotherapy, 2022
- Smad3 Promotes Cancer‐Associated Fibroblasts Generation via Macrophage–Myofibroblast TransitionAdvanced Science, 2021
- A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice modelsActa Pharmaceutica Sinica B, 2021
- Calycosin induces mitochondrial-dependent apoptosis and cell cycle arrest, and inhibits cell migration through a ROS-mediated signaling pathway in HepG2 hepatocellular carcinoma cellsToxicology in Vitro, 2021
- Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinomaBioFactors, 2020
- Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cellsJournal of Cellular Biochemistry, 2019
- Can CpG methylation serve as surrogate markers for immune infiltration in cancer?2019
- Macrophages and cancer: from mechanisms to therapeutic implicationsTrends in Immunology, 2015